Nyu Medical Center Nuclear Med is categorized under Hospitals in New York City, NY and active since 1997.
Nyu Medical Center Nuclear Med was established in 1997, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Elyse Bloom, President at the company’s single location by writing to 560 1st Avenue, New York City, New York NY 10016 or by phoning (212) 263-7410. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nyu Medical Center Nuclear Med |
| Contact Person: | Elyse Bloom, President |
| Address: | 560 1st Avenue, New York City, New York 10016 |
| Phone Number: | (212) 263-7410 |
| Website Address: | nyu.edu |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6211110 |
| Share This Business: |
Nyu Medical Center Nuclear Med was started in 1997 to provide professional Hospitals under the SIC code 8062 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Elyse Bloom, President for inquiries that concern Nyu Medical Center Nuclear Med by calling the company number (212) 263-7410, as your correspondence is most welcome. Additionally, the physical location of the single location of Nyu Medical Center Nuclear Med can be found at the coordinates 40.74297,-73.9741 as well as the street address 560 1st Avenue in New York City, New York 10016.
For its online presence, you may visit Nyu Medical Center Nuclear Med’s website at nyu.edu and engage with its social media outlets through on Twitter and on Facebook.